EUROPEAN CENTRAL COUNCIL
OF HOMEOPATHS
Ensuring patients have access to high
quality homeopathic treatment

News

Latest News

14th November, 2022

European Antibiotic Awareness Day 2022

Resolving AMR by reducing the reliance on antibiotic treatment It needs to become a priority to resolve AMR by reducing reliance on antibiotic medicines. This can be achieved by keeping ...

Read more



11th May, 2022

The Big M: HRT vs natural – homeopathy ‘preferred’ for high breast cancer risk women

Menopause experts discuss the benefits of homeopathy For many women, taking control of perimenopause and menopause is liberating and empowering, during a time where our bodies experience massive biochemical changes. ...

Read more



Future Events

Randomised controlled trials data update 2021

The Homeopathy Research Institute (HRI) is pleased to announce the findings from Dr Robert Mathie’s latest clinical evidence update:

Total number of randomised controlled trials (RCTs):
2021: 255 RCTs of homeopathic treatments for 136 medical conditions

It is promising to see a slight increase in the volume of trials published per year, i.e. 14 RCTs in 2021, compared to 12 RCTs in 2020.

Double-blind placebo-controlled trials (DB-RCTs):
Considering only DB-RCTs in humans, published in peer reviewed journals (excluding prophylaxis and cross-over studies), the analysis found:

2020: 140 trials on 86 different medical conditions
2021148 trials on 88 different medical conditions

148 RCTs of homeopathy (end of 2021)


The 8 new DB-RCTs – 2 positive1,2 0 negative and 6 inconclusive3-8 trials – have resulted in a slight shift in the overall balance of evidence as follows:

Positive:         ↓ 1%
Negative:       ↓ 2%
Inconclusive: ↑ 2%

Our most popular FAQ webpage has been updated to include:

New DB-RCTs: 

  1. Ghosh S, Ravindra RK, Modak A et al. Efficacy of individualized homeopathic medicines in primary dysmenorrhea: a double-blind, randomized, placebo-controlled, clinical trial. J Complement Integr Med 2021 Jun 3. doi: 10.1515/jcim-2020-0512. Online ahead of print.
  2. Shahid S, Ghosh S, Chakraborty AS et al. Efficacy of Individualized Homeopathic Medicines in Plantar Fasciitis: Double-blind, Randomized, Placebo-Controlled Clinical Trial. Homeopathy 2021 Sep 07. DOI: 10.1055/s-0041-1731383. Online ahead of print.
  3. Dey S, Hashmi S, Saha S et al. A Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Individualized Homeopathic Medicines for Cutaneous Warts. Homeopathy 2021 Aug;110(3):149-159
  4. Dey S, Shaikh AR, Saha S et al. Efficacy of Individualized Homeopathic Medicines in the Treatment of Atopic Dermatitis in Adults: A Double-Blind, Randomized, Placebo-Controlled, Preliminary Trial. Complement Med Res2021 Apr 15;1-10
  5. Dolev T, Ben-David M, Shahadi I et al. Attention Dysregulation in Breast Cancer Patients Following a Complementary Alternative Treatment Routine: A Double-Blind Randomized Trial. Integrative Cancer Therapies 2021; 20: 1–10
  6. Dutta S, Ganguly S, Mukherjee SK et al. Efficacy of individualized homeopathic medicines in intervening with the progression of pre-hypertension to hypertension: A double-blind, randomized, placebo-controlled trial. Explore (NY) 2021 Jun 5;S1550-8307(21)00098-7.
  7. Parewa M, Burman AS, Brahma A et al. Individualized Homeopathic Medicines in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled, Pilot Trial. Complement Med Res 2021; 28(5):407-418
  8. Sadhukhan S, Singh S, Michael J et al. Individualized Homeopathic Medicines in Stage I Essential Hypertension: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial. J Altern Complement Med 2021 Jun; 27(6):515-521

Source: HRI